IVI Open-Source Value Project on Display at ISPOR Europe

IVI economists showcased the results of multiple research streams supporting open-source value modeling initiative at the leading European conference for health economics and outcomes research. Presentation topics included: Development of open-source software for conducting value assessments; Implementation of a new approach for using public feedback to guide ongoing, iterative improvement of open-source value models; and [...]

2020-03-19T15:45:26-04:00November 14th, 2018|Events, News|

PRESS RELEASE: IVI Showcases Recent Research Activities as Part of the Open-Source Value Project at ISPOR EU 2018

Los Angeles, CA – November 13, 2018 – The Innovation and Value Initiative (IVI) – a collaboration dedicated to advancing the science and improving the practice of value assessment in healthcare – will present research at this week’s ISPOR Europe 2018 conference showcasing different elements of the Open-Source Value Project (OSVP) initiative to facilitate assessment [...]

2021-03-23T19:00:59-04:00November 13th, 2018|Events, News, Press|

IVI Fosters a Middle Ground for Value Assessment Discussions

In an article published on AJMC.com, IVI'sJennifer Bright and Mark Linthicum argue value assessment stakeholders need to have transparent discussions about value assessment and understand what value means from other points of view. Read the full article here.

2018-11-04T10:39:56-05:00November 2nd, 2018|News, Viewpoints|

Bright at Xtelligent Media Panel: Value Assessment Platform Must Go Beyond Population Averages

IVI's Jennifer Bright participated in a panel of discussion at the recent Value-Based Summit, organized by Xtelligent media. Bright's panel, "Healthcare Quality Measurement," examined how healthcare stakeholders are looking at insights derived from measurement initiatives to support value-based care. Read more here.

2018-11-04T10:27:30-05:00November 1st, 2018|Events, News|

PRESS RELEASE: IVI Discusses the Open-Source Value Project and Its Relevance in Modernizing Cost-Effectiveness Analysis

ISPOR Conference Examines How New Approaches to Value Assessment May Help Move Toward More Informed Pricing Washington, D.C. –- October 19, 2018 -- At the ISPOR Summit 2018, the lead scientific advisor for the Innovation and Value Initiative (IVI) - a collaboration dedicated to advancing the science and improving the practice of value assessment in [...]

2021-03-23T19:02:02-04:00October 19th, 2018|Events, News, Press|

PRESS RELEASE: IVI’s Executive Director Discusses Moving Beyond the Average in Value Assessment

IVI’s Executive Director Discusses Moving Beyond the Average in Value Assessment at Xtelligent Media’s Value Based Summit 2018 Boston, MA –- October 18, 2018 -- Value Assessment 2.0 requires building assessment models that account for all of the factors that determine value instead of focusing only on cost and clinical benefits, said the executive director [...]

2021-03-23T19:02:46-04:00October 18th, 2018|Events, News, Press|

Is One Answer Good Enough for All? Defining Value in Healthcare

While it makes sense for value assessment to be woven into healthcare decision making, relying on a single method to measure value and using this metric to restrict treatment access is shortsighted. IVI's Jennifer Bright and Mark Linthicum address this concern in a recent article for the American Journal of Managed Care (AJMC). Read the [...]

2018-09-11T16:59:01-04:00August 22nd, 2018|News, Viewpoints|

Why Quality Measures Must Reflect Patient Values, Care Experience

There isn't an easy answer to assessing value in healthcare, but IVI is working to tackle the problems through considerable research and experimentation by developing an open-source value platform that considers no only clinical factors, but patient perspectives as well. In a recent interview with PatientEngagementHIT.com, IVI's Jennifer Bright (Executive Director) and Mark Linthicum (Director [...]

2018-08-24T13:13:25-04:00August 20th, 2018|News, Viewpoints|

Is Using Centralized Value Assessment to Make Centralized Pricing Decisions the Most Effective Path Forward?

The Pink Sheet article described comment letters to HHS’ drug pricing blueprint recommending that cost-effectiveness analyses by ICER could help promote value-based pricing in government-sponsored insurance. While IVI concurs value assessment is noble, worthwhile and needed, IVI cautions about making centralized pricing decisions based on centralized value assessments within the U.S.’s current decentralized health care [...]

2018-08-20T12:05:07-04:00August 20th, 2018|News|
Go to Top